Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$3.22 +0.28 (+9.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Selling, General & Administrative (2014 - 2026)

Scinai Immunotherapeutics (SCNI) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Scinai Immunotherapeutics 11.72 Mn -3.10 Bn -1.12 Mn -721,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -721,000.00
Jun 30, 2025 -755,000.00
Mar 31, 2025 -501,000.00
Dec 31, 2024 4.29 Mn
Sep 30, 2024 -764,000.00
Jun 30, 2024 -1.49 Mn
Mar 31, 2024 484,000.00
Dec 31, 2023 7.81 Mn
Sep 30, 2023 -968,000.00
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 967,000.00
Jun 30, 2022 1.29 Mn
Mar 31, 2022 1.45 Mn
Dec 31, 2021 -9.58 Mn
Sep 30, 2021 6.20 Mn
Jun 30, 2021 7.00 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 4.26 Mn